Search bioRxiv⌕ Search

Biology subjects

Moriarty, N.

Publications and source records attributed to Moriarty, N..

5 recordsLinked to original sources

The development of navigation and attentional abilities shapes how children explore naturalistic environments

Exploration is fundamental to how children learn about the world. To explore a new environment comprehensively, a child must navigate without getting lost while simultaneously attending to salient information along the way. Both abilities improve across childhood, yet most studies examine them in isolation, often in constrained spaces with limited sensory complexity. Here, we asked 7- to 14-year-old children (N=42) and young adults (18-22; N=42) to freely explore a large furniture store in immersive virtual reality, which contained many objects and attention-capturing multisensory events. Surprisingly, despite traveling comparable distances, children explored less - they covered less spatial area and examined fewer unique objects than adults. Fine-grained analyses of their behaviors showed that the reduction in exploration was due to children spending more time backtracking and children taking longer to adapt to salient multisensory objects, which were uncorrelated across individuals after controlling for age and independently predicted exploration. However, only backtracking duration predicted success in a subsequent search task, demonstrating a link between navigational success during exploration and the quality of learned spatial representations for later use. Together, the results demonstrate that children explore less comprehensively than adults in large-scale spaces because they are susceptible to getting lost and perseverating on salient events nested within a large environment, but that these behaviors change with age. This suggests that while children are widely considered to be curious explorers within local environments, their ability to do so within larger environments is shaped by the maturation of cognitive systems that integrate experiences over complex contexts.

animal behavior and cognition↗

Lineage-selective suicide gene system enables post-engraftment editing of cell therapy composition

Human pluripotent stem cell (hPSC)-derived therapies are advancing rapidly toward clinical application, yet heterogeneity of transplanted cell populations remains a major barrier to safety, predictability and scalability. Existing strategies to mitigate this risk either incompletely eliminate proliferative cells or ablate the entire graft, thereby compromising therapeutic benefit. Here we present NeuroGuard, a lineage-selective suicide gene platform that decouples safety from efficacy by preserving functional neurons while enabling inducible elimination of all other cell types after transplantation. NeuroGuard integrates an inducible caspase-9 system with NEUROD1-driven Cre recombination, protecting post-mitotic neurons from apoptosis while rendering non-neuronal and proliferative populations susceptible to ablation. In vitro, activation of the system enriched neuronal content to >90% and increased dopaminergic neuron proportion >3-fold. Following transplantation of ventral midbrain progenitors, timed activation eliminated proliferative and glial populations, resulting in compact, neuron-enriched grafts without loss of dopaminergic neuron number, target innervation or behavioural recovery in Parkinsonian rodents. Single-cell transcriptomics confirmed selective removal of non-neuronal lineages while preserving neuronal identity and maturation programs. This work establishes a generalizable framework for post-engraftment editing of cell therapy composition, providing a versatile strategy to enhance the safety and functional predictability of regenerative therapies.

neuroscience↗

Netrin-1 drives cell-type-specific plasticity of human dopaminergic neurons during circuit integration in a Parkinsonian model

The survival of transplanted ventral midbrain (vm) dopaminergic neurons (DAn) and their innervation of host striatal tissue are crucial for ameliorating motor symptoms in Parkinsons disease (PD). However, human pluripotent stem cells (hPSC) show inferior axonal plasticity compared to fetal donor tissue. While modulation of the host environment with trophic cues, such as glial cell-derived neurotrophic factor (GDNF), can improve graft outcomes, these cues lack specificity for DAn, resulting in plasticity of other neurons within the graft. Using single nuclei RNA sequencing, we identified axonal guidance pathways (Semaphorin, Netrin and Wnt) that were preferentially activated in DAn within the graft. Overexpression of Semaphorin3A/SEMA3A, Netrin1/NTN1 or WNT5A in the striatum of Parkinsonian mice following vm DA progenitor transplantation promoted A9-DA specification and selectively increased DA innervation of the host striatum, without off-target extrastriatal DA innervation observed in response to GDNF. In Parkinsonian rats, NTN1 overexpression promoted graft-induced motor recovery, selective DA plasticity and activation of postsynaptic striatal neurons without evidence of non-DAn plasticity. Further, snRNA-sequencing of NTN1 or GDNF-treated grafts confirmed the upregulation of DA-specific plasticity by NTN1, while GDNF promoted plasticity in both DA and non-DAn. These findings highlight the capacity to improve on-target integration of hPSC-derived DAn in grafts by selectively targeting DA-specific plasticity. Taken together, these results demonstrate the utility of DA-specific cues to promote functional recovery, improve graft predictability, and limit off-target innervation.

neuroscience↗

Spatially precise neuron formation via hydrogel mediated modulation of the host astrocyte response

The regenerative capacity of the central nervous system after injury or disease is limited. Advancements in genetic and epigenetic reprogramming of non-neuronal cells into induced neurons presents a promising strategy for neuronal replacement and circuit reconstruction yet is hindered by suboptimal reprogramming efficacy. Here, we have achieved high astrocyte-to-neuron reprogramming efficacy through the ectopic expression of a SOX2 transcription factor using adeno-associated viral vectors. We subsequently designed a hybrid composite biomaterial to act as an implantable reprogramming workshop that perform sequential operations. Once injected, this bespoke system forms a tissue mimetic hydrogel encouraging the ingress of astrocytes to act as our raw material. We demonstrate that the system localized and enhanced the spatially confined delivery of reprogramming factors, entrapping astrocytes to then pass through an intermediate neuroblast state to robustly yield mature neurons. Sustained delivery of valproic acid within the system further promoted neuronal maturation. Overall, using design rules informed by requirements of the reprogramming strategy, we have designed a smart delivery system optimized for both the target tissue and reprogramming factors in a minimally invasive manner to enhance neural repair. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=163 HEIGHT=200 SRC="FIGDIR/small/695501v1_ufig1.gif" ALT="Figure 1"> View larger version (65K): org.highwire.dtl.DTLVardef@397e41org.highwire.dtl.DTLVardef@90047forg.highwire.dtl.DTLVardef@1175831org.highwire.dtl.DTLVardef@19f30eb_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

VIRAL DELIVERY OF GDNF PROMOTES FUNCTIONAL INTEGRATION OF HUMAN STEM CELL GRAFTS IN PARKINSONS DISEASE

The derivation of neurotransmitter and region-specific neuronal populations from human pluripotent stem cells (PSC) provides impetus for advancing cell therapies into the clinic. At the forefront is our ability to generate ventral midbrain (VM) dopaminergic (DA) progenitors, suitable for transplantation in Parkinsons disease (PD). Pre-clinical studies, however, have highlighted the low proportion of DA neurons within these grafts and their inferior plasticity by comparison to human fetal donor transplants. Here we sought to examine whether modification of the host environment, through viral delivery of a developmentally critical molecule, glial cell line-derived neurotrophic factor (GDNF), could improve graft survival, integration and function in Parkinsonian rodents. Utilising LMX1A- and PITX3-GFP hPSC reporter lines, we tracked the response of DA progenitors implanted into either a GDNF-rich environment, or in a second group, after a 3-week delay in onset of exposure. We found that early exposure of the graft to GDNF promoted survival of DA and non-DA cells, leading to enhanced motor recovery in PD rats. Delayed overexpression of intrastriatal GDNF also promoted motor recovery in transplanted rats, through alternate selective mechanisms including enhanced A9/A10 specification, increased DA graft plasticity, greater activation of striatal neurons and elevated DA metabolism. Lastly, transcriptional profiling of the grafts highlighted novel genes underpinning these changes. Collectively these results demonstrate the potential of targeted neurotrophic gene therapy strategies to improve human PSC graft outcomes.

neuroscience↗